Welcome to Prellis Bio

We build biocompatible scaffolds with human-matched tissue resolution and speeds 100x faster than any other technology.

our technology

brings real life to your lab

To test 3D organ and tissue growth Prellis Biologics’ developed Vascular Tissue Blanks™. We now ship our scaffolds to over 30 academic and pharma research labs.  Researchers use our structures to produce guaranteed large 3D organoids and to improve engraftment of tissue in transplant models.  

Vascular Tissue Blanks™ dramatically improve speed, reliability and consistency of 3D cell culture experiments, providing better results.

Real-time printing

with the Holograph-X

MAKING Complex 3D cell culture EASY

 

With Prellis 3D Tissue Blanks™ 3D tissue-like organoids can be produced in minutes by seeding with your desired cell type. Human primary cells including neurons, liver, immune cells, and patient derived breast cancer cells are grown for weeks with low hypoxia and spontaneous formation of complex 3D architecture. Cell layering and co-culture has also been demonstrated. 

Marcus Muench, Ph.D.

Associate Adjunct Professor, UCSF

The [Prellis] structures are also more consistent, so less variability from that perspective too. Less variability means quicker, with less cost and more tests – to results.

Michael Jones, Ph.D.

CEO of Cell Guidance Systems

Their technology provides a radical new dimension in our ability to control cell behaviour by tightly manipulating and controlling micro-scale architecture of 3D culture.

Maria Soloveychik, Ph.D.

CEO of SyntheX

The setup is quick and consistent, and the handling is straightforward.  100% better.

media coverage

Forbes

Laser Printing Human Organs, A New Kidney In 24 Hours? It’s Closer Than You Think.

KPIX San Francisco

Advances Creating Capillaries Bring 3-D Bio Printing Of Organs Closer To Reality

Prellis Biologics

Prellis Biologics Fall Newsletter

Sign Up for Breakthrough Alerts

© Prellis Biologics 2019, All rights reserved.
  • LinkedIn - Grey Circle
  • Twitter
  • Facebook
  • Instagram